Phyton Operates Certified GMP Development and Manufacturing Facilities in Germany and Canada
Phyton Biotech operates the world’s largest Plant Cell Fermentation (PCF®) Technology facility with more than 200,000 litres of fermentation capacity and multiple production lines from kilograms to tonnes of product volumes. With our state-of-the-art facilities, we are uniquely equipped to address the entire development chain, including sourcing/selection of plant material, cell line/fermentation/downstream process development, analytical development, semi-synthesis and scale-up to commercial production.
|PHYTON BIOTECH GERMANY
Ahrensburg, Germany (near Hamburg)
|Commercial production or starting material for paclitaxel and docetaxel API using Plant Cell Fermentation Technology|
|Technology Hub for the development of speciality fermentation solutions|
|PHYTON BIOTECH CANADA
GMP Finished API
|Commercial production of paclitaxel and docetaxel finished API’s|
|Global regulatory compliance & maintenance of drug master files|
|Global commercial sales and distribution|
History and ownership
Phyton was the first company in the world to leverage plant cell fermentation for the development and commercialization of plant-based pharmaceuticals used to treat cancer and other life-threatening illnesses.
At Phyton, we are at the forefront of innovation and excellence in harnessing the potential of phytochemicals using “green” biotechnology. Our mission, vision and values have been core to our success for over 25 years and guide our exceptional people every day in everything they do.